Newly released Survival Data (from ASCO) with Oncosil devise and SOC demonstrates:-
(1) 64% of implanted patients were alive after 12 months.
(2) 50% of implanted patients (21/42) were alive after 16 months.
(3) Average overall survival of 16 months.
Compared to SOC (chemo only) of 9-11 months.
IMO this demonstrates efficacy and should be approved by the regulators.
Ann: Positive Overall Survival data released at ASCO 2019 Chicago, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 192 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6234 | 1 |
View Market Depth
| Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |